Suchergebnisse - "Androgen receptor"

PubPharm (9.245)

1

The opioid peptide leucine enkephalin modulates hypothalamic-hypophysial axis in the cichlid fish Oreochromis mossambicus

enthalten in: Animal reproduction science | 2024

von Shinde, D. | Bhat, S. | Ganesh, C.

2

Filamin A in triple negative breast cancer

enthalten in: Steroids | 2024

von Giovannelli, P. | Di Donato, M. | Licitra, F. | +4

3

Elevated luteinizing hormone receptor signaling or selenium treatment leads to comparable changes in adrenal cortex histology and androgen-AR/ZIP9 signaling

enthalten in: Protoplasma | 2024

von Wieczorek, J. | Pawlicki, P. | Zarzycka, M. | +5

ErratumIn: Protoplasma. 2023 Dec 18;:. - PMID 38105279

4

The opioid peptide β-endorphin interferes with the pituitary-testis axis in the Mozambique tilapia Oreochromis mossambicus

enthalten in: Fish physiology and biochemistry | 2024

von Shinde, D. | Bhat, S. | Ganesh, C.

5

Emerging and traditional 5-α reductase inhibitors and androgen receptor antagonists for male androgenetic alopecia

enthalten in: Expert opinion on emerging drugs | 2024

von Gupta, A. | Talukder, M. | Williams, G.

6

In silico study of androgen receptor N-terminal domain and exploration of its modulators

enthalten in: Journal of biomolecular structure & dynamics | 2024

von Zhang, W. | Hu, H. | Zhu, Y. | +4

7

GRIM19 deficiency aggravates metabolic disorder and ovarian dysfunction in PCOS

enthalten in: Biochimica et biophysica acta. Molecular basis of disease | 2024

von Yang, L. | Yang, Y. | Han, X. | +4

8

Selective Androgen Receptor Modulators-Transformative Drugs or Heralds of the Next Drug Epidemic?

enthalten in: JAMA | 2024

von Hahamyan, H. | Basaria, S.

9

Developing a Novel Enzalutamide-Resistant Prostate Cancer Model via AR F877L Mutation in LNCaP Cells

enthalten in: Current protocols | 2024

von Wang, R. | Ma, S. | Xu, N. | +6

10

Deep and Durable Prostate-specific Antigen Response to Darolutamide with Androgen Deprivation Therapy and Docetaxel, and Association with Clinical Outcomes for Patients with High- or Low-volume Metastatic Hormone-sensitive Prostate Cancer : Analyses of the Randomized Phase 3 ARASENS Study

enthalten in: European urology | 2024

von Saad, F. | Hussain, M. | Tombal, B. | +15

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[925]